Scholtz & Company, LLC Seer, Inc. Transaction History
Scholtz & Company, LLC
- $207 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding SEER
# of Institutions
77Shares Held
35.2MCall Options Held
0Put Options Held
600-
Sb Global Advisers LTD London, X05.14MShares$11.9 Million3.45% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M05.14MShares$11.9 Million0.05% of portfolio
-
Siren, L.L.C. New York, NY4MShares$9.24 Million0.39% of portfolio
-
Black Rock Inc. New York, NY2.64MShares$6.11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.34MShares$5.41 Million0.0% of portfolio
About Seer, Inc.
- Ticker SEER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,566,500
- Market Cap $135M
- Description
- Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...